| 来源类型 | Op-Ed |
| 规范类型 | 评论 |
| Unproven stem cell therapies | |
| Kirstin R.W. Matthews; Ana S. Iltis | |
| 发表日期 | 2015-12-16 |
| 出版年 | 2015 |
| 语种 | 英语 |
| 概述 | The U.S. Food and Drug Administration should work with stakeholders to develop new policy guidelines that prevent stem cell clinics ... |
| 摘要 | The U.S. Food and Drug Administration should work with stakeholders to develop new policy guidelines that prevent stem cell clinics from promoting unproven stem cell interventions to patients, the authors write in a Houston Chronicle op-ed. |
| 主题 | Center for Health and Biosciences |
| URL | https://www.bakerinstitute.org/research/finding-new-approach-stem-cell-regulation/ |
| 来源智库 | James A. Baker III Institute for Public Policy (United States) |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/79619 |
| 推荐引用方式 GB/T 7714 | Kirstin R.W. Matthews,Ana S. Iltis . Unproven stem cell therapies. 2015. |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
